Trial-in-Progress: Brentuximab Vedotin in Combination with Lenalidomide and Rituximab in Subjects with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) - Bartlett, Nancy L.; Yasenchak, Christopher A.; Sims, Robert B.; Nowakowski, Grzegorz S. (Blood, 2020)